Tandem Diabetes Care, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tandem Diabetes Care, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 87% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 63% of Healthcare companies in United States.
Cash Locked Ratio
$24For every $100 of sales, $24 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
More money tied up than 52% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
−$52Sales grew 27% in 3 years, but profit fell: $52 less profit per $100 of extra sales.
Lower than 82% of Healthcare companies in United States.
Asset Productivity Ratio
+27% / -16%In 3 years sales changed by +27% while total assets changed by -16%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-0.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 68% of Healthcare companies in United States.
Cash Cushion Ratio
−13%Debt, after subtracting cash, equals 13% of its market value (net debt).
Lower than 80% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 87% of Healthcare companies in United States.
Tangible Net Worth Ratio
92%Of every $100 of net worth, $92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 76% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Tandem Diabetes Care, Inc. made a loss over the last year. Tandem Diabetes Care, Inc. owes $0.89 for every $1 it owns. Tandem Diabetes Care, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTandem Diabetes Care, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
9.30The share price is 9.30 times Tandem Diabetes Care, Inc.'s book value per share, higher than 85% of Healthcare companies in United States.
Market cap
$1.2 BThe total market value of all of Tandem Diabetes Care, Inc.'s shares at today's price (share price × number of shares), larger than 67% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$130 MWhat Tandem Diabetes Care, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.87Net worth divided by the number of shares. The share price of $17.43 is 9.3 times this, which is the P/B above.
Return on equity (ROE)
-48.0%Tandem Diabetes Care, Inc. lost 48.0% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.
Owes vs Owns
0.89×Tandem Diabetes Care, Inc. owes $0.89 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Dividend yield
NoneTandem Diabetes Care, Inc. does not currently pay a dividend.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit growth
LossTandem Diabetes Care, Inc. made a loss in each of the last two years.
Profit margin
-20.2%Tandem Diabetes Care, Inc. lost $20 for every $100 of revenue.
Interest cover
Not coveredTandem Diabetes Care, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTandem Diabetes Care, Inc. had $152 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tandem Diabetes Care, Inc.: $1.2 B ÷ $130 M (30 Jun 2026) = 9.3.
What is Tandem Diabetes Care, Inc.'s return on equity?
Tandem Diabetes Care, Inc. lost 48.0% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.
How much does Tandem Diabetes Care, Inc. owe compared with what it owns?
Tandem Diabetes Care, Inc. owes $0.89 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Does Tandem Diabetes Care, Inc. pay a dividend?
No. Tandem Diabetes Care, Inc. does not currently pay a dividend.
Is Tandem Diabetes Care, Inc.'s revenue growing?
Revenue rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.